BILL · 2005–06 SESSION

HB 1884: High-technology excise tax

Disallowing high-technology excise tax incentives for certain pharmaceutical manufacturing companies.

Summary

Provides that a pharmaceutical manufacturing company shall not claim credit under RCW 82.04.4452 if: (1) The company has reduced sales to retail pharmacies in Canada within the twelve months prior to the effective date of this act or at any time after the effective date of this act, pursuant to a company policy issued in response to the direct and indirect sales of company products to residents of the United States…

From the Bill Digest (HB 1884), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to high-technology excise tax incentives for pharmaceutical manufacturing companies;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

HB 1884 (2025–26) Cannabis regulation · Did not pass · died in committee
HB 1884 (2023–24) Cancer drugs coverage · Did not pass · died in committee
HB 1884 (2021–22) Forensic election audits · Did not pass · died in committee
HB 1884 (2019–20) Election cert. & training · Did not pass · died in committee
HB 1884 (2017–18) Mobile home park tenants · Did not pass · passed House, stalled in Senate
HB 1884 (2015–16) Electric mobility devices · Enacted · Chapter 145, Laws of 2015
HB 1884 (2013–14) Occupational diseases · Did not pass · passed House, stalled in Senate
HB 1884 (2011–12) Econ development commission · Did not pass · died in committee